DCF Tool

TFX

Teleflex Incorporated – Surgical and Medical Instrument Manufacturing
Teleflex is a global provider of medical technologies designed to improve the health and quality of people’s lives. The Company applys purpose driven innovation – a relentless pursuit of identifying unmet clinical needs – to benefit patients and healthcare providers. Its portfolio is diverse, with solutions in the fields of vascular access, interventional cardiology and radiology, anesthesia, emergency medicine, surgical, urology and respiratory care. Teleflex employees worldwide are united in the understanding that what we do every day makes a difference.
Analysis Results
Intrinsic Value $373.16
Latest Price $285.47
Relative Value 23% undervalued
Thoughts on this result? Let us know.
Ad
Cash Flow (Billions)
Analysis Parameters
%
%
%
New Ticker
Ad
Analysis Details
Growth Rate Projection

An exponential growth model was fit to the past cash flow data, giving more weight to more recent years. This model determined a growth rate estimate of 11.0%.

Weighted Average Cost of Capital (WACC)

The calculated WACC is 7.2%. This value is used as the default discount rate.

Value of Future Flows

Assuming a growth rate of 11.0%, the cash flows for the next 5 years are projected.

The present value of each year's flow is adjusted to present value using the discount rate.

Year Future flow (billion) Present value (billion)
2022 0.718 0.67
2023 0.797 0.693
2024 0.884 0.717
2025 0.981 0.742
2026 1.09 0.768
Terminal Value

Assuming a growth rate after the projection years of 2.0%, the terminal value of the company would be 21.2 billion. This corresponds to a present value of 13.9 billion.

Intrinsic Value Per Share

The total present value of the projected cash flows is 3.59 billion. Adding in the terminal value gives a total present value of 17.5 billion.

There are presently 46.9 million outstanding shares, so the intrinsic value per share is 373.16.

Financial Statements

The following data was to determine the past cash flows.

Current Assets 1,429,118,000
Current Cash 445,084,000
Current Liabilities 680,119,000
Current Debt 110,000,000
Non-Cash Working Capital (NCWC) 413,915,000
Change in NCWC -193,103,000
EBIT 558,676,000
Tax Provision 74,349,000
Depreciation and Amortization 237,362,000
Capital Expenditure -71,618,000
Unlevered Free Cash Flow 457,073,250
Current Assets 1,422,425,000
Current Cash 375,880,000
Current Liabilities 540,027,000
Current Debt 100,500,000
Non-Cash Working Capital (NCWC) 607,018,000
Change in NCWC 114,824,000
EBIT 461,559,000
Tax Provision 21,931,000
Depreciation and Amortization 227,252,000
Capital Expenditure -90,694,000
Unlevered Free Cash Flow 684,644,816
Current Assets 1,306,332,000
Current Cash 301,083,000
Current Liabilities 563,055,000
Current Debt 50,000,000
Non-Cash Working Capital (NCWC) 492,194,000
Change in NCWC 109,017,000
EBIT 443,382,000
Tax Provision -122,078,000
Depreciation and Amortization 214,062,000
Capital Expenditure -102,695,000
Unlevered Free Cash Flow 663,766,000
Current Assets 1,236,169,000
Current Cash 357,161,000
Current Liabilities 582,456,000
Current Debt 86,625,000
Non-Cash Working Capital (NCWC) 383,177,000
Change in NCWC -14,821,000
EBIT 399,546,000
Tax Provision 23,196,000
Depreciation and Amortization 209,980,000
Capital Expenditure -80,795,000
Unlevered Free Cash Flow 471,711,969
Current Assets 1,128,807,000
Current Cash 333,558,000
Current Liabilities 483,876,000
Current Debt 86,625,000
Non-Cash Working Capital (NCWC) 397,998,000
Change in NCWC 2,969,000
EBIT 387,069,000
Tax Provision 129,648,000
Depreciation and Amortization 155,263,000
Capital Expenditure -70,903,000
Unlevered Free Cash Flow 298,263,271
Current Assets 1,183,393,000
Current Cash 543,789,000
Current Liabilities 427,646,000
Current Debt 183,071,000
Non-Cash Working Capital (NCWC) 395,029,000
Change in NCWC -26,266,000
EBIT 374,313,000
Tax Provision 8,074,000
Depreciation and Amortization 117,906,000
Capital Expenditure -53,135,000
Unlevered Free Cash Flow 400,518,872
Current Assets 1,006,431,000
Current Cash 338,366,000
Current Liabilities 666,712,000
Current Debt 419,942,000
Non-Cash Working Capital (NCWC) 421,295,000
Change in NCWC -62,180,000
EBIT 323,302,000
Tax Provision 7,838,000
Depreciation and Amortization 108,393,000
Capital Expenditure -61,448,000
Unlevered Free Cash Flow 297,709,008
Current Assets 1,053,209,000
Current Cash 303,236,000
Current Liabilities 634,899,000
Current Debt 368,401,000
Non-Cash Working Capital (NCWC) 483,475,000
Change in NCWC -6,262,000
EBIT 302,731,000
Tax Provision 28,650,000
Depreciation and Amortization 111,133,000
Capital Expenditure -67,571,000
Unlevered Free Cash Flow 300,626,869
Current Assets 1,200,554,000
Current Cash 431,984,000
Current Liabilities 635,120,000
Current Debt 356,287,000
Non-Cash Working Capital (NCWC) 489,737,000
Change in NCWC 27,402,000
EBIT 271,713,000
Tax Provision 23,547,000
Depreciation and Amortization 92,976,000
Capital Expenditure -63,580,000
Unlevered Free Cash Flow 292,102,725
Current Assets 1,069,079,000
Current Cash 337,039,000
Current Liabilities 274,405,000
Current Debt 4,700,000
Non-Cash Working Capital (NCWC) 462,335,000
Change in NCWC 32,188,000
EBIT 237,458,000
Tax Provision 16,413,000
Depreciation and Amortization 80,468,000
Capital Expenditure -65,394,000
Unlevered Free Cash Flow 284,720,000

This analysis is provided for informational purposes only and does not constitute financial or investing advice. For more information on the advantages and limitations of DCF analysis see background. This information is provided on an "as is" basis. No warranty, expressed or implied, is made regarding accuracy, adequacy, completeness, legality, reliability or usefulness of any information. By using this site you agree that under no circumstances shall Valuation Tools LLC be held liable for any loss or damage caused by information obtained from this website including any articles, data, videos, its social media accounts, or any other materials.